Preventing postoperative nausea and vomiting: Post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant

Current Medical Research and Opinion

Volumn 23, Issue 10, 2007, Pages 2559-2565

  Diemunsch, Pierre ^a   Apfel, Christian ^b   Gan, Tong J ^c   Candiotti, Keith ^d   Philip, Beverly K ^e   Chelly, Jacques ^f   Carides, Alexandra D ^g   Evans, Judith K ^g   Ho, Tony W ^g   Reiss, Theodore ^g  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^g MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Antiemetic; Aprepitant; Emesis; NK1 antagonist; Ondansetron; Postoperative nausea and vomiting

Indexed keywords

APREPITANT; ONDANSETRON;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GENERAL ANESTHESIA; HUMAN; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; POSTOPERATIVE NAUSEA AND VOMITING; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIEMETICS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; POSTOPERATIVE NAUSEA AND VOMITING; TREATMENT OUTCOME;

EID: 35648952233     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X233115     Document Type: Conference Paper

References (13)

1. Apfel CC, Läärä E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting. Anesthesiology 1999;91:693-700
2. Cohen MM, Duncan PG, DeBoer DP, et al. The postoperative interview: assessing risk factors for nausea and vomiting. Anesth Analg 1994;78:7-16
3. Koivuranta M, Läärä E, Snåre L, et al. A survey of postoperative nausea and vomiting. Anaesthesia 1997;52:449
4. Rust M, Cohen LA. Single oral dose ondansetron in the prevention of postoperative nausea and emesis. Anaesthesia 1994;49:16-23
5. Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 1992;77:162-84
6. Gan TJ, Ginsberg B, Grant AP, et al. Double-blind, randomized comparison of ondansetron and intraoperative propofol to prevent postoperative nausea and vomiting. Anesthesiology 1996;85:1036-42
7. Merck & Co., Inc. Emend® capsules (aprepitant). In: Physicians Desk Reference. 61st Edition. Thomson PDR: Montvale, NJ, USA, 2007, pp.1963-9
8. Gan TJ, Apfel CC, Kovac A, et al. A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. Anesthes Analges 2007;104:1082-9
9. Diemunsch P, Gan TJ, Philip BK, et al. Single-dose aprepitant versus ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery. Br J Anaesth 2007;99:202-11
10. Tramer MR, Martin R, Reynolds DJM, et al. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology 1997;87:1277-89
11. Stadler M, Bardiau F, Seidel L, et al. Difference in risk factors for postoperative nausea and vomiting. Anesthesiology 2003;98:46-52
12. Boogaerts JG, Vanacker E, Seidel L, et al. Assessment of postoperative nausea using a visual analogue scale. Acta Anaesthesiol Scand 2000;44:470-4
13. Gan TJ. Risk factors for postoperative nausea and vomiting. Anesth Analg 2006;102:1884-98